Antisense development has required diligent efforts by many labs to allow it to progress. Improved methods have helped to transgress many barriers, resulting in a vibrant technology geared towards generating new human therapuetics.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Phosphorothioate oligonucleotides, suramin and heparin inhibit DNA-dependent protein kinase activity
British Journal of Cancer Open Access 02 April 2002
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zamecnik, P.C. & Stephenson, M.L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. natn. Acad. Sci. U.S.A. 75, 280–284 (1978).
Stein, C.A. & Krieg, A.M. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Dev. 4, 67–69 (1994).
Wagner, R.W. Gene inhibition using anti-sense oligodeoxynucleotides. Nature 372, 333–335 (1994).
Wagner, R.W. et al. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 260, 1510–1513 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wagner, R. The state of the art in antisense research. Nat Med 1, 1116–1118 (1995). https://doi.org/10.1038/nm1195-1116
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1195-1116
This article is cited by
-
Inhibition of granuloma‐associated angiogenesis by controlling mast cell mediator release: role of mast cell protease‐5
British Journal of Pharmacology (2005)
-
Phosphorothioate oligonucleotides, suramin and heparin inhibit DNA-dependent protein kinase activity
British Journal of Cancer (2002)
-
Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells
Oncogene (2002)
-
Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1)
British Journal of Pharmacology (2000)
-
Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide
Nature Biotechnology (1999)